Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Medical genetics

Ocugen
Health / Medical

Ocugen Secures ATMP Classification for Gene Therapies Targeting Vision Loss

March 5, 2025March 4, 2025 - by Timothy Alexander

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that the European Commission has granted Advanced Therapy Medicinal Product (ATMP) classifications for its gene therapies OCU410 and OCU410ST. This regulatory milestone …

Ocugen Secures ATMP Classification for Gene Therapies Targeting Vision Loss Read More

National Comprehensive Cancer Network
Cancer

NCCN Publishes Vital Patient Resource on Genetic Testing for Hereditary Cancers

January 22, 2025January 21, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) has released a new resource aimed at helping individuals understand genetic testing and counseling for hereditary cancers. This patient-friendly guide provides …

NCCN Publishes Vital Patient Resource on Genetic Testing for Hereditary Cancers Read More

Trending News

  • Palvella Therapeutics Launches Awareness Campaign for Rare Lymphatic Disease

  • Retail Theft Suspect Sought After Exton Shoe Store Incident

  • VA, DOJ Partnership Expands Legal Support for Vulnerable Veterans

  • FDA Launches Real-Time Safety Database for Drugs and Vaccines

  • New Caregiver Tool Reaches Thousands Across Pennsylvania

Subscribe for Updates

Follow Us

  • Facebook
  • X
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Suspect

Retail Theft Suspect Sought After Exton Shoe Store Incident

2 hours ago4 hours ago

Department of Veterans Affairs

VA, DOJ Partnership Expands Legal Support for Vulnerable Veterans

3 hours ago24 hours ago

PA CareKit

New Caregiver Tool Reaches Thousands Across Pennsylvania

13 hours agoMarch 15, 2026

Copyright © 2026 MyChesCo.